Zhejiang Ausun Pharmaceutical Future Growth
Future criteria checks 6/6
Zhejiang Ausun Pharmaceutical is forecast to grow earnings and revenue by 27.3% and 25.3% per annum respectively. EPS is expected to grow by 26.8% per annum. Return on equity is forecast to be 20.3% in 3 years.
Key information
27.3%
Earnings growth rate
26.8%
EPS growth rate
Pharmaceuticals earnings growth | 20.1% |
Revenue growth rate | 25.3% |
Future return on equity | 20.3% |
Analyst coverage | Low |
Last updated | 30 Oct 2023 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 1,501 | 517 | N/A | 415 | 2 |
12/31/2024 | 1,165 | 387 | N/A | 321 | 2 |
12/31/2023 | 925 | 305 | N/A | 267 | 2 |
9/30/2023 | 858 | 284 | -66 | 18 | N/A |
6/30/2023 | 852 | 273 | 14 | 136 | N/A |
3/31/2023 | 822 | 258 | -59 | 168 | N/A |
12/31/2022 | 765 | 235 | -151 | 121 | N/A |
9/30/2022 | 718 | 213 | -232 | 113 | N/A |
6/30/2022 | 665 | 186 | -299 | 41 | N/A |
3/31/2022 | 631 | 173 | -156 | 173 | N/A |
12/31/2021 | 570 | 146 | -137 | 174 | N/A |
9/30/2021 | 537 | 131 | -70 | 221 | N/A |
6/30/2021 | 485 | 117 | 5 | 227 | N/A |
3/31/2021 | 474 | 110 | -30 | 120 | N/A |
12/31/2020 | 409 | 87 | 46 | 138 | N/A |
9/30/2020 | 406 | 72 | 55 | 104 | N/A |
6/30/2020 | 389 | 78 | 60 | 121 | N/A |
3/31/2020 | 329 | 70 | 26 | 80 | N/A |
12/31/2019 | 308 | 56 | 38 | 88 | N/A |
9/30/2019 | 293 | 62 | 11 | 78 | N/A |
6/30/2019 | 257 | 51 | -14 | 43 | N/A |
3/31/2019 | 252 | 50 | -38 | 29 | N/A |
12/31/2018 | 244 | 44 | -44 | 12 | N/A |
9/30/2018 | 255 | 54 | -13 | 46 | N/A |
6/30/2018 | 266 | 52 | -24 | 36 | N/A |
3/31/2018 | 251 | 43 | -10 | 41 | N/A |
12/31/2017 | 240 | 53 | -5 | 49 | N/A |
9/30/2017 | 217 | 55 | -2 | 43 | N/A |
6/30/2017 | 216 | 62 | N/A | 108 | N/A |
3/31/2017 | 197 | 58 | N/A | 114 | N/A |
12/31/2016 | 199 | 57 | N/A | 93 | N/A |
3/31/2016 | 259 | 62 | N/A | 41 | N/A |
12/31/2015 | 263 | 61 | N/A | 54 | N/A |
12/31/2014 | 201 | 22 | N/A | 21 | N/A |
12/31/2013 | 121 | 16 | N/A | 16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 603229's forecast earnings growth (27.3% per year) is above the savings rate (2.9%).
Earnings vs Market: 603229's earnings (27.3% per year) are forecast to grow faster than the CN market (23.8% per year).
High Growth Earnings: 603229's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 603229's revenue (25.3% per year) is forecast to grow faster than the CN market (14.4% per year).
High Growth Revenue: 603229's revenue (25.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 603229's Return on Equity is forecast to be high in 3 years time (20.3%)